EGFR overexpression and its aberrant activity occur in over 90% of HNSCC cases and represent an independent prognostic marker correlating with increased tumor size, decreased radiation sensitivity, and increased risk of recurrence39. Here, EGFR is linked to head and neck squamous cell carcinoma.